Jean-Sebastien Frenel
Advertisement
Articles by Jean-Sebastien Frenel
82 Efficacy, Safety, and Biomarker Analysis of ICARUS-BREAST01: A Phase 2 Study of Patritumab Deruxtecan (HER3-DXd) in Patients With HR+/HER2– Advanced Breast Cancer
ByBarbara Pistilli,Livia Pierotti,Magali Lacroix-Triki,Cecile Vicier,Jean-Sebastien Frenel,Véronique D’Hondt,Florence Dalenc,Thomas Bachelot,Agnes Ducoulombier,Marc-Antoine Benderra,Delphine Loirat,Didier Mayeur,Ghada B. Nachabeh,Andrea Sporchia,Fumitaka Suto,Stefan Michiels,Noemie Corcos,Fernanda Mosele,Fabrice André, Guillaime Montagnac
Advertisement
Latest Updated Articles
22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEEPublished: June 24th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
2
Phase 2 Trial Will Evaluate CD19 t-haNK Combo in Indolent Lymphomas
3
FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC
4
How Would the Teclistamab Combo Approval Transform Multiple Myeloma?
5